Pharma Journalist - Page 27 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Stay Ahead in RNAi: Join 80+ Leaders Shaping 2026 Innovation

FDA Grants Breakthrough Status to Ionis’ Drug for Alexander Disease

FDA Expands Approval of Lilly’s Jaypirca for Earlier CLL/SLL Treatment

Formosa Pharmaceuticals Grants Rxilient Rights to New Ophthalmic Drug

AGC Biologics Expands Cell Line Center With ATUM Partnership

FDA Names Tracy Beth Høeg as Acting Director of Drug Evaluation Center

FDA Proposes New Guidance to Reduce Non-Human Primate Testing

Citizen Health and UCB Launch AI-Driven Partnership for Rare Diseases

IQVIA Partners with AWS to Advance Agentic AI in Life Sciences

FDA Grants Breakthrough Status to Ionis’ Olezarsen for sHTG